Massive Bio uses artificial intelligence to support clinical trials of new cancer therapies. As we work toward our goals of helping cancer patients discover new hope through clinical trials and advancing medical science, Massive Bio is also fostering important new developments in the age of artificial intelligence. Cagatay Culcuoglu, chief technology officer at Massive Bio, talks about our company’s technology and future.

We are striving to create a world where all cancer patients can access clinical trials quickly and without barriers. Massive Bio took the lead in this mission, and we are working tirelessly to make it a reality.